Dicobalt edetate
Brand names: Kelocyanor
Dicobalt edetate is a cobalt-based chelating antidote used for severe, life-threatening cyanide poisoning.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
The cobalt moiety binds cyanide ions to form stable, relatively non-toxic cobalt-cyanide complexes that are excreted, removing cyanide from the circulation.
Prescribing in practice
- Reserve strictly for confirmed or strongly suspected severe cyanide poisoning, as it is itself toxic and can cause serious reactions (including hypotension and facial/laryngeal oedema) if given in the absence of cyanide.
- Administer only by clinicians familiar with its use, with full resuscitation facilities immediately available.
- Follow with supportive care and consider intravenous glucose, as recommended in current prescribing references.
Monitoring
Monitor cardiovascular status, airway and clinical response continuously during and after administration.
Counselling the patient
- Explain to the team that this is an emergency antidote for cyanide poisoning.
- Highlight the risk of severe adverse reactions if cyanide exposure is not actually present.
- Ensure resuscitation equipment is to hand before use.
Evidence & guidelines
Dicobalt edetate is recognised as an antidote for severe cyanide poisoning, with use guided by national poisons information services such as TOXBASE.
Reference: TOXBASE / NPIS; AAGBI; SmPC; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Difficult Airway Algorithm (DAS) · DAS 2015; Royal College of Anaesthetists
- Major Haemorrhage Protocol · NICE NG24; UK MHP guidelines
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
Dicobalt edetate is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.